Smoking duration, intensity, and risk of Parkinson disease

Neurology

Volumn 74, Issue 11, 2010, Pages 878-884

  Chen, H ^a   Huang, X ^b   Guo, X ^c   Mailman, R B ^b   Park, Y ^d   Kamel, F ^a   Umbach, D M ^a   Xu, Q ^a   Hollenbeck, A ^e   Schatzkin, A ^d   Blair, A ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c Westat Inc   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; EXAMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; RISK; AGED; LIFESTYLE; MIDDLE AGED; QUESTIONNAIRE; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TIME;

AGE FACTORS; AGED; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK; SEX FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 77950505354     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d55f38     Document Type: Article

References (27)

1. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal- Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-284.
2. Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology 2002;58:581-588.
3. Mellick GD, Gartner CE, Silburn PA, Battistutta D. Passive smoking and Parkinson disease. Neurology 2006;67:179-180.
4. O'Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol 2009;169:678-682.
5. Quik M, O'Neill M, Perez XA. Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacol Sci 2007;28:229-235.
6. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health- American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-1125.
7. Chen H, Jacobs E, Schwarzschild MA, et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005;58:963-967.
8. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Diet and Parkinson's disease: A potential role of dairy products in men. Ann Neurol 2002;52:793-801.
9. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 2007;68:764-768.
10. Rkz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007;64:990-997.
11. Hernan MA, Zhang SM, Rueda-de Castro AM, Colditz GA, Speizer FE, Ascherio A. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 2001;50:780-786.
12. Grandinetti A, Morens DM, Reed D, MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-1138.
13. Elbaz A, Bower JH, Peterson BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota Arch Neurol 2003;60:91-96.
14. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord 2006;21:1002-1007.
15. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005;57:27-33. (Pubitemid 40053312)
16. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000;2:421-426.
17. Shihara LI, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 2006;21: 1066-1072.
18. Evans AH, Lawrence AD, Potts J, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:317-321.
19. Morozova N, O'Reilly EJ, Ascherio A. Variations in gender ratios support the connection between smoking and Parkinson's disease. Mov Disord 2008;23:1414-1419.
20. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 2004;27:561-568.
21. Vieregge A, Sieberer M, Jacobs H, Hagenah JM, Vieregge P. Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology 2001;57:1032-1035.
22. Lemay S, Chouinard S, Blanchet P, et al. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:31-39.
23. Ebersbach G, Stock M, Muller J, Wenning G, Wissel J, Poewe W. Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration. Mov Disord 1999;14:1011-1013.
24. Clemens P, Baron JA, Coffey D, Reeves A. The short-term effect of nicotine chewing gum in patients with Parkinson's disease. Psychopharmacology 1995;117:253-256.
25. Villafane G, Cesaro P, Rialland A, et al. Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. Eur J Neurol 2007;14:1313-1316.
26. Alves G, Kurz M, Lie SA, Larsen JP. Cigarette smoking in Parkinson's disease: influence on disease progression. Mov Disord 2004;19:1087-1092.
27. Kandinov B, Giladi N, Korczyn AD. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. Parkinsonism Relat Disord 2007;13:243-245.